Log In
Print this Print this

Cethrin (BA-210)

  Manage Alerts
Collapse Summary General Information
Company BioAxone Therapeutics Inc.
DescriptionRecombinant C3 exoenzyme protein, a Rho GTPase antagonist, mixed with a fibrin sealant
Molecular Target Rho GTPase
Mechanism of ActionSealant
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II/III
Standard IndicationSpinal cord injury (SCI)
Indication DetailsTreat acute cervical spinal cord injury (SCI); Treat acute spinal cord injury (SCI); Treat traumatic spinal cord injury (SCI)
Regulatory Designation EU - Orphan Drug (Treat traumatic spinal cord injury (SCI))
PartnerAlseres Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today